Open the map

Boston ScientificBSX

Medtech & devices · NYSE · USA

$42.04
Up 1.1% todayClose

Down 56.4% this year and −5.0% since June 26, behind the life science sector at +10.7%. Boston Scientific supplies 1 mapped company.

This year
−56.4%
1 year
−56.6%
P/E
16.5
P/S
2.9
P/B
2.4

Price vs the life science sector

since Jun 26BSXLife science sector, equal weight
Boston Scientific (BSX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BSX: −5.0% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%+15%Jun 26AugSepOct 8BSX −5.0%Sector +10.7% Boston Scientific (BSX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BSX: −5.0% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%Jun 26AugSepOct 8BSX−5.0%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedCardinal Health (CAH)CAHCardinal Health+2.9%BSXBoston Scientif… Open the full chain →

About Boston Scientific

Cardiology drives the growth, particularly electrophysiology, where Farapulse sits, and structural heart treatment. Endoscopy and urology cover the rest of the range.

Theme exposure

MedtechCardiologyElectrophysiology

Products

  • Electrophysiology (Farapulse)
  • Structural heart
  • Endoscopy & urology

Competitors

Risks

  • Competition in electrophysiology
  • Acquisition integration

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Compare BSX

Side by side with the largest companies in the same segment.

See where Boston Scientific sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →